Search

everythinglearnresearchcommunity

for

Search:↓

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Oclacitinib maleate successfully treated alopecia in Andean bears.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

Combining fractionated CO2 laser with tacrolimus may help treat chronic alopecia areata.

Candida antigen is an effective and promising treatment for alopecia areata.

Squaric acid dibutylester effectively treats alopecia areata.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

New micelle solutions greatly improve skin delivery of certain antifungal drugs.

Fexofenadine reduces discomfort but doesn't significantly improve hair regrowth in Alopecia Areata treatment.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Fludalanine failed as an effective oral antibiotic despite efforts.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

A new lotion with halobetasol and tazarotene successfully treats acne keloidalis nuchae.

The new micelle formulation delivers acne treatment more effectively and safely than current gels.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Angelica Dahurica extract helps reduce hair loss and improve hair growth and scalp condition.

Zinc may help treat alopecia areata by boosting certain immune cells.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

An arthritis drug helped a person with severe hair loss regrow their hair.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.